Loading viewer...
annual_report
Format: PDF annual_report
Rapala VMC Corporation's 2023 full year results showing net sales of 201.2 MEUR and comparable operating profit of 5.6 MEUR, impacted by macroeconomic headwinds and retail destocking. The company expects 2024 comparable operating profit to increase as market conditions improve and centralized manufacturing normalizes operations.
annual_report
78 Pages
ACCO Brands
Alembic Pharmaceuticals Annual Report 2007
annual_reportannual_report
72 Pages
Alembic Pharmaceuticals
annual_report
Carter’s